These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 28981353

  • 1. Modified 3-Point MRI-Based Tumor Regression Grade Incorporating DWI for Locally Advanced Rectal Cancer.
    Lee MA, Cho SH, Seo AN, Kim HJ, Shin KM, Kim SH, Choi GS.
    AJR Am J Roentgenol; 2017 Dec; 209(6):1247-1255. PubMed ID: 28981353
    [Abstract] [Full Text] [Related]

  • 2. Prognostic Value of Tumor Regression Grade on MR in Rectal Cancer: A Large-Scale, Single-Center Experience.
    Yoen H, Park HE, Kim SH, Yoon JH, Hur BY, Bae JS, Kim JH, Oh HJ, Han JK.
    Korean J Radiol; 2020 Sep; 21(9):1065-1076. PubMed ID: 32691542
    [Abstract] [Full Text] [Related]

  • 3. Diffusion-weighted MRI and MR- volumetry--in the evaluation of tumor response after preoperative chemoradiotherapy in patients with locally advanced rectal cancer.
    Birlik B, Obuz F, Elibol FD, Celik AO, Sokmen S, Terzi C, Sagol O, Sarioglu S, Gorken I, Oztop I.
    Magn Reson Imaging; 2015 Feb; 33(2):201-12. PubMed ID: 25460330
    [Abstract] [Full Text] [Related]

  • 4. Value of percent change in tumoral volume measured at T2 -weighted and diffusion-weighted MRI to identify responders after neoadjuvant chemoradiation therapy in patients with locally advanced rectal carcinoma.
    Quaia E, Gennari AG, Ricciardi MC, Ulcigrai V, Angileri R, Cova MA.
    J Magn Reson Imaging; 2016 Dec; 44(6):1415-1424. PubMed ID: 27219471
    [Abstract] [Full Text] [Related]

  • 5. Image Quality Assessment of 2D versus 3D T2WI and Evaluation of Ultra-high b-Value (b=2,000 mm/s2) DWI for Response Assessment in Rectal Cancer.
    Hausmann D, Liu J, Budjan J, Reichert M, Ong M, Meyer M, Smakic A, Grimm R, Strecker R, Schoenberg SO, Wang X, Attenberger UI.
    Anticancer Res; 2018 Feb; 38(2):969-978. PubMed ID: 29374729
    [Abstract] [Full Text] [Related]

  • 6. [Predictive value of combination of MRI tumor regression grade and apparent diffusion coefficient for pathological complete remission after neoadjuvant treatment of locally advanced rectal cancer].
    Xu N, Huang FC, Li WL, Luan X, Jiang YM, He B.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Apr 25; 24(4):359-365. PubMed ID: 33878826
    [Abstract] [Full Text] [Related]

  • 7. Comparison of diffusion-weighted MRI and MR volumetry in the evaluation of early treatment outcomes after preoperative chemoradiotherapy for locally advanced rectal cancer.
    Kim YC, Lim JS, Keum KC, Kim KA, Myoung S, Shin SJ, Kim MJ, Kim NK, Suh J, Kim KW.
    J Magn Reson Imaging; 2011 Sep 25; 34(3):570-6. PubMed ID: 21751285
    [Abstract] [Full Text] [Related]

  • 8. Comparison between MRI and pathology in the assessment of tumour regression grade in rectal cancer.
    Sclafani F, Brown G, Cunningham D, Wotherspoon A, Mendes LST, Balyasnikova S, Evans J, Peckitt C, Begum R, Tait D, Tabernero J, Glimelius B, Roselló S, Thomas J, Oates J, Chau I.
    Br J Cancer; 2017 Nov 07; 117(10):1478-1485. PubMed ID: 28934761
    [Abstract] [Full Text] [Related]

  • 9. Value of diffusion-weighted MRI and apparent diffusion coefficient measurements for predicting the response of locally advanced rectal cancer to neoadjuvant chemoradiotherapy.
    Iannicelli E, Di Pietropaolo M, Pilozzi E, Osti MF, Valentino M, Masoni L, Ferri M.
    Abdom Radiol (NY); 2016 Oct 07; 41(10):1906-17. PubMed ID: 27323759
    [Abstract] [Full Text] [Related]

  • 10. Diffusion-weighted MRI for Early Prediction of Treatment Response on Preoperative Chemoradiotherapy for Patients With Locally Advanced Rectal Cancer: A Feasibility Study.
    Jacobs L, Intven M, van Lelyveld N, Philippens M, Burbach M, Seldenrijk K, Los M, Reerink O.
    Ann Surg; 2016 Mar 07; 263(3):522-8. PubMed ID: 26106836
    [Abstract] [Full Text] [Related]

  • 11. A rectal cancer feasibility study with an embedded phase III trial design assessing magnetic resonance tumour regression grade (mrTRG) as a novel biomarker to stratify management by good and poor response to chemoradiotherapy (TRIGGER): study protocol for a randomised controlled trial.
    Battersby NJ, Dattani M, Rao S, Cunningham D, Tait D, Adams R, Moran BJ, Khakoo S, Tekkis P, Rasheed S, Mirnezami A, Quirke P, West NP, Nagtegaal I, Chong I, Sadanandam A, Valeri N, Thomas K, Frost M, Brown G.
    Trials; 2017 Aug 29; 18(1):394. PubMed ID: 28851403
    [Abstract] [Full Text] [Related]

  • 12. Best MRI predictors of complete response to neoadjuvant chemoradiation in locally advanced rectal cancer.
    Sathyakumar K, Chandramohan A, Masih D, Jesudasan MR, Pulimood A, Eapen A.
    Br J Radiol; 2016 Aug 29; 89(1060):20150328. PubMed ID: 26828967
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Magnetic resonance imaging-detected tumor response for locally advanced rectal cancer predicts survival outcomes: MERCURY experience.
    Patel UB, Taylor F, Blomqvist L, George C, Evans H, Tekkis P, Quirke P, Sebag-Montefiore D, Moran B, Heald R, Guthrie A, Bees N, Swift I, Pennert K, Brown G.
    J Clin Oncol; 2011 Oct 01; 29(28):3753-60. PubMed ID: 21876084
    [Abstract] [Full Text] [Related]

  • 15. The role of MRI after neochemoradiotherapy in predicting pathological tumor regression grade and clinical outcome in patients with locally advanced rectal adenocarcinoma.
    Niu S, Chen Y, Peng F, Wen J, Xiong J, Yang Z, Peng J, Bao Y, Ding L.
    Front Oncol; 2023 Oct 01; 13():1118518. PubMed ID: 37377906
    [Abstract] [Full Text] [Related]

  • 16. Locally advanced rectal cancer: added value of diffusion-weighted MR imaging for predicting tumor clearance of the mesorectal fascia after neoadjuvant chemotherapy and radiation therapy.
    Park MJ, Kim SH, Lee SJ, Jang KM, Rhim H.
    Radiology; 2011 Sep 01; 260(3):771-80. PubMed ID: 21846762
    [Abstract] [Full Text] [Related]

  • 17. Comparison of magnetic resonance imaging and histopathological response to chemoradiotherapy in locally advanced rectal cancer.
    Patel UB, Brown G, Rutten H, West N, Sebag-Montefiore D, Glynne-Jones R, Rullier E, Peeters M, Van Cutsem E, Ricci S, Van de Velde C, Kjell P, Quirke P.
    Ann Surg Oncol; 2012 Sep 01; 19(9):2842-52. PubMed ID: 22526897
    [Abstract] [Full Text] [Related]

  • 18. Magnetic resonance imaging tumor response score (mrTRS) predicts therapeutic effect and prognosis of locally advanced rectal cancer after neoadjuvant chemoradiotherapy: A prospective, multi-center study.
    Guan Z, Sun RJ, Cao WT, Zhang HM, Yu T, Yu XP, Zhang JX, Zhang XY, Li XT, Zhou ZY, Zhao XM, Wen L, Sun YS.
    Radiother Oncol; 2020 Oct 01; 151():288-295. PubMed ID: 32890612
    [Abstract] [Full Text] [Related]

  • 19. CT texture analysis in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy: A potential imaging biomarker for treatment response and prognosis.
    Chee CG, Kim YH, Lee KH, Lee YJ, Park JH, Lee HS, Ahn S, Kim B.
    PLoS One; 2017 Oct 01; 12(8):e0182883. PubMed ID: 28797063
    [Abstract] [Full Text] [Related]

  • 20. Interpretation of Complete Tumor Response on MRI Following Chemoradiotherapy of Rectal Cancer: Inter-Reader Agreement and Associated Factors in Multi-Center Clinical Practice.
    Kim HY, Cho SH, Jang JK, Kim B, Lee CM, Lim JS, Moon SK, Oh SN, Seo N, Park SH.
    Korean J Radiol; 2024 Apr 01; 25(4):351-362. PubMed ID: 38528693
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.